- Home
- TXMD vs MDCX Comparison
TXMD vs MDCX Comparison
Compare TXMD & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TXMD | MDCX |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | 12 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9M | 26.2M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | TXMD | MDCX |
|---|---|---|
| Price | $2.23 | $1.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 33.0K | ★ 523.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.61 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,761,000.00 | N/A |
| Revenue This Year | $427.09 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $90.64 | ★ N/A |
| Revenue Growth | ★ 35.25 | N/A |
| 52 Week Low | $0.72 | $0.92 |
| 52 Week High | $2.95 | $8.90 |
Technical Indicators
Market Signals| Indicator | TXMD | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 49.23 | 57.81 |
| Support Level | $1.05 | $1.14 |
| Resistance Level | $2.54 | $1.43 |
| Average True Range (ATR) | 0.13 | 0.19 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 40.91 | 62.93 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.